Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Peer-reviewed studies relevant to GHK-Cu are listed in the Citations tab on this product page
Future you will thank you
Recent trials have shown: Up to 20% body weight reduction with weekly GLP-1 agonists (Wilding et al., NEJM) Improvements in HbA1c, fasting glucose, and cardiovascular outcomes (Marso et al., NEJM) This drug class is now widely used for: Obesity (with or without diabetes) Type 2 diabetes PCOS-related insulin resistance Metabolic syndrome Common Side Effects and Patient Concerns Despite their benefits, GLP-1 agonists are not without risks or drawbacks
But copper peptides are fragile
US$ 29.79
US$ 19.98
US$ 21.30
US$ 25.36
US$ 21.39
US$ 25.91
US$ 26.11
US$ 29.81
US$ 28.43
